Pavise

The useful diligence case is whether the test material matches the sold formula, whether effects persist in ordinary use and whether human evidence supports the breadth of commercial language. A February 2026 ex vivo human-skin platform paper is a research milestone, not proof that a finished serum reverses ageing in customers; full-text appraisal and product-level clinical evidence remain incomplete.